IE
CALA

Israel Englander’s Calithera Biosciences, Inc CALA Stock Holding History

Israel Englander’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,160
Closed -$260K – 7841
2022
Q1 		$260K Buy
32,160
+6,065
+23% +$62K ﹤0.01% 5670
2021
Q4 		$347K Sell
26,095
-10,862
-29% -$273K ﹤0.01% 5394
2021
Q3 		$1.61M Sell
36,957
-23,675
-39% -$1.02M ﹤0.01% 4158
2021
Q2 		$2.53M Buy
60,632
+48,658
+406% +$2.14M ﹤0.01% 3660
2021
Q1 		$580K Buy
+11,974
New +$697K ﹤0.01% 4702
2020
Q4 		– Sell
-8,745
Closed -$603 – 5744
2020
Q3 		$603 Sell
8,745
-13,770
-61% -$1.2M ﹤0.01% 3477
2020
Q2 		$2.38M Buy
22,515
+20,744
+1,171% +$2.46M ﹤0.01% 2396
2020
Q1 		$157K Sell
1,771
-15,339
-90% -$1.83M ﹤0.01% 3465
2019
Q4 		$1.95M Buy
17,110
+10,751
+169% +$809K ﹤0.01% 2634
2019
Q3 		$392K Buy
+6,359
New +$509K ﹤0.01% 3412
2019
Q1 		– Sell
-3,163
Closed -$254K – 4449
2018
Q4 		$254K Buy
3,163
+389
+14% +$38.4K ﹤0.01% 3302
2018
Q3 		$291K Sell
2,774
-3,229
-54% -$307K ﹤0.01% 3495
2018
Q2 		$600K Sell
6,003
-29,654
-83% -$3.36M ﹤0.01% 3082
2018
Q1 		$4.49M Sell
35,657
-36,322
-50% -$5.66M 0.01% 1876
2017
Q4 		$12M Buy
71,979
+47,872
+199% +$12.3M 0.02% 1208
2017
Q3 		$7.59M Buy
24,107
+12,628
+110% +$3.98M 0.01% 1422
2017
Q2 		$3.41M Buy
11,479
+7,713
+205% +$2.06M 0.01% 1751
2017
Q1 		$870K Buy
3,766
+3,190
+554% +$551K ﹤0.01% 2480
2016
Q4 		$37K Sell
576
-4,538
-89% -$283K ﹤0.01% 3266
2016
Q3 		$332K Buy
5,114
+257
+5% +$16.6K ﹤0.01% 2777
2016
Q2 		$360K Buy
4,857
+3,832
+374% +$384K ﹤0.01% 2649
2016
Q1 		$116K Sell
1,025
-212
-17% -$24K ﹤0.01% 3061
2015
Q4 		$190K Buy
+1,237
New +$186K ﹤0.01% 3109
2015
Q2 		– Sell
-1,262
Closed -$414K – 4003
2015
Q1 		$414K Sell
1,262
-12,901
-91% -$4.59M ﹤0.01% 2851
2014
Q4 		$5.72M Buy
+14,163
New +$3.7M 0.01% 1301

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's CALA Position: Q2 2022 in Review

Israel Englander sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 32,160 shares — an estimated $260K sold.

Israel Englander first reported a position in CALA in Q4 2014 and held it in 25 quarters. The position peaked at $12M in Q4 2017. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • Israel Englander reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • Israel Englander sold 32,160 Calithera Biosciences, Inc shares in Q2 2022, an estimated $260K.
  • Israel Englander first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 25 quarters.
  • Israel Englander's Calithera Biosciences, Inc position peaked at $12M in Q4 2017.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.